Related Experiment Video
Updated: Jan 24, 2026

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
Improving the Developability of an Antigen Binding Fragment by Aspartate Substitutions
Laila I Sakhnini1,2, Per J Greisen1, Charlotte Wiberg1
1Global Research Technologies , Novo Nordisk A/S , 2760 Måløv , Denmark.
Engineering antibody fragments with aspartate substitutions significantly enhances developability by improving stability and reducing aggregation without impacting binding affinity. This strategy offers a rapid method for developing better antibody-based therapeutics.
Area of Science:
- Biotechnology
- Pharmaceutical Science
- Protein Engineering
Background:
- Antibody aggregation poses a significant challenge in pharmaceutical development, affecting product quality during manufacturing and administration.
- Early developability assessment is crucial for identifying and removing problematic antibody molecules, but it is resource-intensive.
- Strategies for engineering enhanced developability are highly sought after to streamline drug discovery.
Purpose of the Study:
- To investigate if aspartate (Asp) substitutions can improve the developability of a murine antigen-binding fragment (Fab).
- To assess the impact of Asp substitutions on thermodynamic stability, aggregation propensity, nonspecificity, and binding affinity of the Fab.
Main Methods:
- A combinatorial library of 393 Fab variants with varying Asp substitutions was created.
- In silico screening using Rosetta predicted thermodynamic stability for variant selection.
- Selected variants underwent production and rigorous developability studies, including stability, aggregation, and binding assays.
Main Results:
- Most engineered Fab variants demonstrated thermodynamic stability comparable to or better than the wild type.
- Twenty-five variants showed improved nonspecificity, and half exhibited enhanced aggregation resistance.
- Crucially, Asp substitutions improved developability without substantially affecting the antigen-binding affinity.
Conclusions:
- Combining negative charge insertion (Asp substitutions) with in silico screening rapidly enhances Fab developability.
- This approach successfully improved aggregation resistance and stability while maintaining binding affinity.
- The findings provide a valuable strategy for engineering antibody-based therapeutics with improved developability profiles.
Related Concept Videos
Ligand Binding and Linkage
Habitat Fragmentation
Nuclear Binding Energy
The Equilibrium Binding Constant and Binding Strength
The Equilibrium Binding Constant and Binding Strength
Diazonium Group Substitution: –OH and –H

